Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
CSPC Pharmaceutical Group, headquartered in Hong Kong, is a leading Chinese pharmaceutical company. It focuses on the research, development, production, and marketing of innovative drugs for respiratory diseases, cancer, cardiovascular diseases, and infectious diseases. CSPC Pharmaceutical Group drives pharmaceutical innovation, delivering high-quality medications to meet global health needs.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
CSPC Pharmaceutical Group is scheduled to report its next quarterly earnings on 11/13/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
CSPC Pharmaceutical Group last reported quarterly earnings on 8/20/2026 (Q2 2026). Earnings per share (EPS) came in at 0.53 HKD.
Across its last 3 earnings reports, CSPC Pharmaceutical Group stock moved by ±3.2% on average the following day. The largest reaction was -5.4% on 05/27/2026; 2 of 3 reactions were positive.
CSPC Pharmaceutical Group has beaten analyst EPS estimates in 1 of its last 6 evaluated quarters (beat rate: 16.7%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 6 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.